Biotest AG/ DE0005227235 /
2024-08-28 5:13:06 PM | Chg. - | Volume | Bid4:09:04 PM | Ask4:08:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
25.60EUR | - | 1,602 Turnover: 37,898 |
-Bid Size: - | -Ask Size: - | 1.62 bill.EUR | 0.10% | - |
Assets
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 232 | 230.7000 | 234.9000 | 243 | 254.9000 | ||||||
Intangible Assets | 66.7000 | 64.9000 | 62.8000 | 54.6000 | 48.1000 | ||||||
Long-Term Investments | .2000 | 19.3000 | 4.7000 | .2000 | .2000 | ||||||
Fixed Assets | 308.2000 | 323.4000 | 312.8000 | 314.9000 | 324 | ||||||
Inventories | 170.3000 | 148.7000 | 153 | 184.2000 | 227 | ||||||
Accounts Receivable | 96 | 98.3000 | 121 | 96.1000 | 118.5000 | ||||||
Cash and Cash Equivalents | 6.7000 | 18.5000 | 83.2000 | 57.2000 | 204.4000 | ||||||
Current Assets | 325.3000 | 308.9000 | 370 | 349 | 562.5000 | ||||||
Total Assets | 633.5000 | 632.3000 | 682.8000 | 682.3000 | 886.5000 |
Liabilities
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 40.6000 | 42.8000 | 34.7000 | 47.4000 | 51.4000 | ||||||
Long-term debt | 153.7000 | 132.2000 | 101.3000 | 71 | 226.2000 | ||||||
Liabilities to Banks | 204.5000 | 161.1000 | 139 | 112.4000 | 231.5000 | ||||||
Provisions | 39.9000 | 34.8000 | 43.2000 | 35.6000 | 47.7000 | ||||||
Liabilities | 363.6000 | 324.7000 | 336.1000 | 312.9000 | 425.8000 | ||||||
Share Capital | 30 | 30 | 30 | 30 | 33.8000 | ||||||
Total Equity | 264.8000 | 301.6000 | 346.6000 | 369.3000 | 460.6000 | ||||||
Minority Interests | 5.1000 | 6 | .1000 | .1000 | .1000 | ||||||
Total liabilities equity | 633.5000 | 632.3000 | 682.8000 | 682.3000 | 886.5000 |
Income Statement
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 440.2000 | 412.5000 | 422 | 440 | 500.8000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 61.5000 | 42.9000 | 41.6000 | 44.7000 | 53.8000 | ||||||
Interest Income | - | - | -13.5000 | -9.2000 | -7 | ||||||
Income Before Taxes | 49 | 28.5000 | 28.6000 | 36.5000 | 47.8000 | ||||||
Income Taxes | 17.1000 | 8.8000 | 9.9000 | 13.4000 | 15.8000 | ||||||
Minority Interests Profit | -3.9000 | -2.5000 | -1.8000 | 0.0000 | 0.0000 | ||||||
Net Income | 28 | 36.9000 | 46.4000 | 33.4000 | 32 |
Per Share
Cash Flow
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 32.7000 | 77.8000 | 72.3000 | 34.7000 | -7.2000 | ||||||
Cash Flow from Investing Activities | -39.8000 | -16.8000 | 22 | -29.3000 | -32.3000 | ||||||
Cash Flow from Financing | 6.8000 | -48.3000 | -30.7000 | -31.4000 | 186.9000 | ||||||
Decrease / Increase in Cash | -1.3000 | 12.7000 | 63.6000 | -26 | 147.4000 | ||||||
Employees | 1,834 | 1,721 | 1,774 | 1,870 | 2,160 |